Molecular Assay Assesses Asymptomatic Malaria
By LabMedica International staff writers Posted on 03 Jan 2012 |
In malaria endemic areas, molecular techniques allow a more accurate assessment of the asymptomatic parasite burden in the local population.
In these areas, individuals frequently have no symptoms and go undetected by conventional microscopy or newer, rapid diagnostic tests (RDTs), but the parasites can be detected by polymerase chain reaction (PCR).
A study was carried out under the auspices of the London School of Hygiene and Tropical Medicine (UK), in a region of northeastern Tanzania to determine the relative prevalence of submicroscopic level parasite carriage and clonal complexity of infections over a range of endemicities. This study used 1,121 blood samples collected from a previously conducted cross-sectional malariometric survey during the short rainy season in 2001 from 13 villages at three different altitudes. Samples were analyzed by PCR for carriage of parasites and multiplicity of infection. The data was compared with other measures of transmission intensity collected from the same area. The PCR was carried out in a tetrad thermo-cycler (PTC-0240, The DNA engine Tetrad2 Thermal Cycler, Bio-Rad; Hercules, CA, USA), followed by gel electrophoresis to assign individuals as either parasite positive or negative.
A 2.5-fold difference was observed when parasite prevalence was compared between PCR at 34.7% and 13.6% by microscopy. This fold difference was relatively consistent at the different altitude bands despite a marked decrease in parasite prevalence with altitude. Multiplicity of infection (MOI) ranged from 1.2 to 3.7 and was positively associated with parasite prevalence assessed by both PCR and microscopy. There was no association of MOI and age. The difference between parasite prevalence by PCR was 3.2 in individuals aged between 15 and 45 years compared with 2.5 in those aged from one to five years.
The authors concluded that a large number of individuals carried submicroscopic parasites in a malaria endemic area of Tanzania and they are a potential reservoir of infection in the population. These infections are important as potential contributors to the infectious reservoir of parasites and need to be identified by control programs especially in this era where malaria elimination is a focus. High throughput standardized PCR approaches are needed to identify individuals who are malaria carriers. The study was published online on December 16 2011 in the Malaria Journal.
Related Links:
London School of Hygiene and Tropical Medicine
Bio-Rad
In these areas, individuals frequently have no symptoms and go undetected by conventional microscopy or newer, rapid diagnostic tests (RDTs), but the parasites can be detected by polymerase chain reaction (PCR).
A study was carried out under the auspices of the London School of Hygiene and Tropical Medicine (UK), in a region of northeastern Tanzania to determine the relative prevalence of submicroscopic level parasite carriage and clonal complexity of infections over a range of endemicities. This study used 1,121 blood samples collected from a previously conducted cross-sectional malariometric survey during the short rainy season in 2001 from 13 villages at three different altitudes. Samples were analyzed by PCR for carriage of parasites and multiplicity of infection. The data was compared with other measures of transmission intensity collected from the same area. The PCR was carried out in a tetrad thermo-cycler (PTC-0240, The DNA engine Tetrad2 Thermal Cycler, Bio-Rad; Hercules, CA, USA), followed by gel electrophoresis to assign individuals as either parasite positive or negative.
A 2.5-fold difference was observed when parasite prevalence was compared between PCR at 34.7% and 13.6% by microscopy. This fold difference was relatively consistent at the different altitude bands despite a marked decrease in parasite prevalence with altitude. Multiplicity of infection (MOI) ranged from 1.2 to 3.7 and was positively associated with parasite prevalence assessed by both PCR and microscopy. There was no association of MOI and age. The difference between parasite prevalence by PCR was 3.2 in individuals aged between 15 and 45 years compared with 2.5 in those aged from one to five years.
The authors concluded that a large number of individuals carried submicroscopic parasites in a malaria endemic area of Tanzania and they are a potential reservoir of infection in the population. These infections are important as potential contributors to the infectious reservoir of parasites and need to be identified by control programs especially in this era where malaria elimination is a focus. High throughput standardized PCR approaches are needed to identify individuals who are malaria carriers. The study was published online on December 16 2011 in the Malaria Journal.
Related Links:
London School of Hygiene and Tropical Medicine
Bio-Rad
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read moreMolecular Diagnostics
view channel
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read more
Blood Test Could Identify Patients at Risk for Severe Scleroderma
Systemic sclerosis, also known as scleroderma, causes the hardening of the skin and connective tissues. In many cases, the disease can also damage vital organs, including the heart, kidneys, lungs, and... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more